Porton Pharma Solutions Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,255.818 million compared to CNY 925.265 million a year ago. Operating income was CNY 236.940 million compared to CNY 137.134 million a year ago. Net income was CNY 214.568 million compared to CNY 130.944 million a year ago. Basic earnings per share from continuing operations was CNY 0.39 compared to CNY 0.25 a year ago.